124 related articles for article (PubMed ID: 7719488)
1. Quantitative analysis of phosphorothioate oligonucleotides in biological fluids using direct injection fast anion-exchange chromatography and capillary gel electrophoresis.
Bourque AJ; Cohen AS
J Chromatogr B Biomed Appl; 1994 Dec; 662(2):343-9. PubMed ID: 7719488
[TBL] [Abstract][Full Text] [Related]
2. Determination of antisense phosphorothioate oligonucleotides and catabolites in biological fluids and tissue extracts using anion-exchange high-performance liquid chromatography and capillary gel electrophoresis.
Chen SH; Qian M; Brennan JM; Gallo JM
J Chromatogr B Biomed Sci Appl; 1997 Apr; 692(1):43-51. PubMed ID: 9187382
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of phosphorothioate oligonucleotides in biological fluids using fast anion-exchange chromatography.
Bourque AJ; Cohen AS
J Chromatogr; 1993 Jul; 617(1):43-9. PubMed ID: 8376536
[TBL] [Abstract][Full Text] [Related]
4. Selectivity of anion exchange chromatography and capillary gel electrophoresis for the analysis of phosphorothioate oligonucleotides.
Srivatsa GS; Klopchin P; Batt M; Feldman M; Carlson RH; Cole DL
J Pharm Biomed Anal; 1997 Dec; 16(4):619-30. PubMed ID: 9502158
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of the related substances in phosphorothioate antisense oligonucleotide FT19].
Zhang H; Lu D; Wu L; Zhou Z; Wang S
Se Pu; 2008 Sep; 26(5):540-3. PubMed ID: 19160749
[TBL] [Abstract][Full Text] [Related]
6. Characterization and quantification of Bcl-2 antisense G3139 and metabolites in plasma and urine by ion-pair reversed phase HPLC coupled with electrospray ion-trap mass spectrometry.
Dai G; Wei X; Liu Z; Liu S; Marcucci G; Chan KK
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Oct; 825(2):201-13. PubMed ID: 16111926
[TBL] [Abstract][Full Text] [Related]
7. On-column electroextraction and separation of antisense oligonucleotides in human plasma by capillary gel electrophoresis.
Palm AK; Marko-Varga G
J Pharm Biomed Anal; 2004 May; 35(3):415-23. PubMed ID: 15137967
[TBL] [Abstract][Full Text] [Related]
8. A specific picomolar hybridization-based ELISA assay for the determination of phosphorothioate oligonucleotides in plasma and cellular matrices.
Wei X; Dai G; Marcucci G; Liu Z; Hoyt D; Blum W; Chan KK
Pharm Res; 2006 Jun; 23(6):1251-64. PubMed ID: 16718617
[TBL] [Abstract][Full Text] [Related]
9. Analysis of antisense oligonucleotides by capillary electrophoresis, gel-slab electrophoresis, and HPLC: a comparison.
Gelfi C; Perego M; Morelli S; Nicolin A; Righetti PG
Antisense Nucleic Acid Drug Dev; 1996; 6(1):47-53. PubMed ID: 8783795
[TBL] [Abstract][Full Text] [Related]
10. Analytical study of phosphorothioate analogues of oligodeoxynucleotides using high-performance liquid chromatography.
Agrawal S; Tang JY; Brown DM
J Chromatogr; 1990 Jun; 509(2):396-9. PubMed ID: 2211903
[No Abstract] [Full Text] [Related]
11. Capillary gel electrophoresis and antisense therapeutics. Analysis of DNA analogs.
DeDionisio LA; Lloyd DH
J Chromatogr A; 1996 May; 735(1-2):191-208. PubMed ID: 8767742
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and metabolism of an oligodeoxynucleotide phosphorothioate (GEM91) in cynomolgus monkeys following intravenous infusion.
Grindel JM; Musick TJ; Jiang Z; Roskey A; Agrawal S
Antisense Nucleic Acid Drug Dev; 1998 Feb; 8(1):43-52. PubMed ID: 9512095
[TBL] [Abstract][Full Text] [Related]
13. Comparison of pharmacokinetics and tissue disposition of an antisense phosphorothioate oligonucleotide targeting human Ha-ras mRNA in mouse and monkey.
Yu RZ; Geary RS; Leeds JM; Watanabe T; Moore M; Fitchett J; Matson J; Burckin T; Templin MV; Levin AA
J Pharm Sci; 2001 Feb; 90(2):182-93. PubMed ID: 11169535
[TBL] [Abstract][Full Text] [Related]
14. In vivo pharmacokinetics of phosphorothioate oligonucleotides containing contiguous guanosines.
Agrawal S; Tan W; Cai Q; Xie X; Zhang R
Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):245-9. PubMed ID: 9212919
[No Abstract] [Full Text] [Related]
15. Absorption, tissue distribution and in vivo stability in rats of a hybrid antisense oligonucleotide following oral administration.
Agrawal S; Zhang X; Lu Z; Zhao H; Tamburin JM; Yan J; Cai H; Diasio RB; Habus I; Jiang Z
Biochem Pharmacol; 1995 Aug; 50(4):571-6. PubMed ID: 7646565
[TBL] [Abstract][Full Text] [Related]
16. Stability measurement of oligonucleotides in serum samples using capillary electrophoresis.
Khan K; Liekens K; Van Aerschot A; Van Schepdael A; Hoogmartens J
J Chromatogr B Biomed Sci Appl; 1997 Nov; 702(1-2):69-76. PubMed ID: 9449557
[TBL] [Abstract][Full Text] [Related]
17. Development of an ion-pair reverse-phase liquid chromatographic/tandem mass spectrometry method for the determination of an 18-mer phosphorothioate oligonucleotide in mouse liver tissue.
Murphy AT; Brown-Augsburger P; Yu RZ; Geary RS; Thibodeaux S; Ackermann BL
Eur J Mass Spectrom (Chichester); 2005; 11(2):209-15. PubMed ID: 16046805
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of phosphorothioate oligonucleotides in human plasma.
Leeds JM; Graham MJ; Truong L; Cummins LL
Anal Biochem; 1996 Mar; 235(1):36-43. PubMed ID: 8850544
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of modified antisense oligonucleotides in biological fluids using cationic nanoparticles for solid-phase extraction.
Gerster M; Schewitz J; Fritz H; Maier M; Bayer E
Anal Biochem; 1998 Sep; 262(2):177-84. PubMed ID: 9750130
[TBL] [Abstract][Full Text] [Related]
20. Quantitative capillary gel electrophoresis assay of phosphorothioate oligonucleotides in pharmaceutical formulations.
Srivatsa GS; Batt M; Schuette J; Carlson RH; Fitchett J; Lee C; Cole DL
J Chromatogr A; 1994 Oct; 680(2):469-77. PubMed ID: 7981828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
